In Vivo Laboratory Technician

Asgard Therapeutics is a private biotech company aiming to advance cancer immunotherapies by harnessing direct in-vivo cell fate reprogramming technologies. Formed as a spin-off from Lund University, in Sweden, we are pioneering a gene therapy approach based on our proprietary lead program AT-108, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells.